T2 Biosystems Stock (NASDAQ: TTOO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 126.00 / 315.44K |
Day Range | - - - |
52 Wk Range | 2.60 - 70.00 |
Market Cap | $81.92M |
P/E Ratio | 0.05 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 2.57% |
Days to Cover | 1.76 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of T2 Biosystems (NASDAQ:TTOO) through any online brokerage.
Other companies in T2 Biosystems’s space includes: Serina Therapeutics (AMEX:SER), Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Vistagen Therapeutics (NASDAQ:VTGN) and Sangamo Therapeutics (NASDAQ:SGMO).
There is no analysis for T2 Biosystems.
T2 Biosystems has a consensus price target of $1.53.
The stock price for T2 Biosystems (NASDAQ: TTOO) is $4.8002 last updated July 19, 2024 at 7:25 PM EDT.
There are no upcoming dividends for T2 Biosystems.
T2 Biosystems’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for T2 Biosystems.
T2 Biosystems is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.